Resmed Inc. buy Citigroup Inc.
Start price
15.06.26
/
50%
€166.40
Target price
15.06.27
€232.47
Performance (%)
12.47%
Price
29.07.26
€187.15
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 12.47%. This prediction currently runs until 15.06.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 10.707% | 10.707% |
| iShares Core DAX® | 1.014% | 2.699% |
| iShares Nasdaq 100 | -6.470% | -8.771% |
| iShares Nikkei 225® | -6.517% | -12.580% |
| iShares S&P 500 | -2.721% | -1.752% |
Comments by Citigroup_Inc_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (RMD) had its price target lowered by Citigroup Inc. to $270.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat